纳指生物科技ETF(513290)
动态评分： 5.70分
投资组合
| 报告日期 | 代码 | 名称 | 类型 | 金额(万元) | 占期初比 |
| 2023-12-31 | CRNX | Crinetics Pharmaceuticals Inc | 买入 | 170.7 | 2.27% |
| 2023-12-31 | ABCM | Abcam plc ADR | 买入 | 169.47 | 2.25% |
| 2023-12-31 | IMCR | Immunocore Holdings plc ADR | 买入 | 165.92 | 2.2% |
| 2023-12-31 | HRMY | Harmony Biosciences Holdings Inc | 买入 | 162.01 | 2.15% |
| 2023-12-31 | VCYT | Veracyte Inc | 买入 | 161.06 | 2.14% |
| 2023-12-31 | SWTX | SpringWorks Therapeutics Inc | 买入 | 157.5 | 2.09% |
| 2023-12-31 | RXRX | Recursion Pharmaceuticals Inc-A | 买入 | 156.59 | 2.08% |
| 2023-12-31 | GPCR | Structure Therapeutics Inc ADR | 买入 | 155.38 | 2.06% |
| 2023-12-31 | IOVA | Iovance Biotherapeutics Inc | 买入 | 151.16 | 2.01% |
| 2023-12-31 | RXDX | Prometheus Biosciences Inc | 卖出 | 120.92 | 1.61% |
| 2023-12-31 | RETA US | Reata Pharmaceuticals Inc | 卖出 | 119.26 | 1.58% |
| 2023-12-31 | SYNH | Syneos Health Inc-A | 卖出 | 103.16 | 1.37% |
| 2023-06-30 | AMGN | 安进 | 买入 | 696.64 | 9.25% |
| 2023-06-30 | GILD | 吉利德科学 | 买入 | 635.6 | 8.44% |
| 2023-06-30 | REGN | 再生元制药 | 买入 | 594.92 | 7.9% |
| 2023-06-30 | VRTX | 福泰制药 | 买入 | 579.04 | 7.69% |
| 2023-06-30 | MRNA | Moderna Inc | 买入 | 381.85 | 5.07% |
| 2023-06-30 | AZN | 阿斯利康(US ADR) | 买入 | 288.63 | 3.83% |
| 2023-06-30 | BIIB | 生化基因 | 买入 | 276.53 | 3.67% |
| 2023-06-30 | SGEN | Seagen Inc | 买入 | 242.38 | 3.22% |
公告&资料
